For patients with pulmonary sarcoidosis, methotrexate is noninferior to prednisone with regard to the change from baseline to ...

Treatment practices in the U.S. show approximately 75% of diagnosed pulmonary sarcoidosis patients require treatment with ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted ...

For initial treatment of symptomatic pulmonary sarcoidosis, methotrexate appeared to work as well as prednisone over 24 weeks ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted ...

A new biologic drug has been given to a patient with pulmonary sarcoidosis for the first time. The drug, infliximab, was administered at the John Radcliffe Hospital, part of Oxford University ...

In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...

In a groundbreaking study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, Illinois ...

Shukla, M.D., M.S., President and Chief Executive Officer of aTyr. “The program’s cornerstone is our Phase 3 EFZO-FIT™ study ...

As the effects of wildfires persist in several parts of the United States, McGowan highlighted a public health alert ...

A solitary pulmonary nodule (SPN) is an isolated lung growth surrounded by normal tissue. Most SPNs are benign (not cancerous) when they're diagnosed. However, some nodules that enlarge and change ...